Selbyville, Delaware, United States, Novemba 4 2020 (Wiredrelease) Global Market Insights, Inc. Ingxelo yemizi-mveliso idwelisa abo bakhuphisana nabo phambili kwaye inikezela ngolwazi kuhlalutyo lomzi mveliso wezinto eziphambili ezinefuthe kwintengiso.
Intengiso yentengiso yehlabathi ye-viscosuplementation kulindeleke ukuba ibone ukukhula okukhulu ngenxa yeemeko ezandayo ze-osteoarthritis kuluntu lonke lwe-geriatric. I-Osteoarthritis ichaphazela ngokudibeneyo amalungu ezandleni, emadolweni, emqolo, nasezinqeni, kwaye inoxanduva lokuvelisa iindleko zonyango oluphezulu phakathi kwabaguli. Phakathi kwezi, i-osteoarthritis yedolo lolona hlobo luqhelekileyo lwe-arthritis, echaphazela izigidi zabantu kwihlabathi jikelele.
Isicelo sekopi yesampulu yale ngxelo @ https://www.gminsights.com/request-sample/detail/4212
Ngokwengxelo ye-Osteoarthritis Foundation, abantu abangaphezu kwezigidi ezingama-300 banesifo samathambo. Eli chibi likhulu kwaye lihlala likhula liqikelelwa ukuba libe nefuthe elihle ekukhuleni kweemarike kule minyaka izayo. IViscosupplementation yinkqubo encinci yokungenelela yonyango engadingi ukuba abaguli benziwe utyando lokutshintsha amadolo, nto leyo edala imfuno ephezulu yenkqubo kunye nokwandisa imbonakalo yoshishino.
Ngelixa kuncipha kancinci, unyango lwe-viscosupplementation ikwabonelela ngezibonelelo ezininzi ezinje ngokwenza kube lula kwizigulana ukuhamba, ukuhlala nokuhlala, ukunciphisa ukudumba nokungonwabi kumalungu achaphazelekayo, kunye nokuphucula indlela yokuphila yemihla ngemihla yezigulana, yiyo loo nto isifo samathambo abaguli bakhetha inkqubo, bonyusa ukuphunyezwa kwayo konke.
Ngokwengxelo yophando ye-GMI Inc, intengiso ye-viscosupplementation yeemarike inokuthi igqithe kuqikelelo lwe-5.3 yezigidigidi ngo-2026.
Ngokwimveliso, intengiso ye-viscosupplementation iyonke yahlulwe yatofa i-5, inaliti ezi-3 kunye nenaliti enye. Phakathi kwezi, icandelo le-3 lenaliti kuqikelelwa ukuba lirekhode ukukhula okumangalisayo kule minyaka izayo ngenxa yokwanda kokwamkelwa kunye nokufumaneka kweemveliso ezininzi zentengiso zonyango lwe-osteoarthritis. Ngapha koko, icandelo labamba ixabiso elingaphezulu kwe- $ 1.3 yezigidigidi kwi-2019.
Unyango lwe-3 lonyango lwenziwa ngokuhamba rhoqo ngeveki kwaye lunokunciphisa ngokufanelekileyo isixa seentlungu ezifunyanwa sisigulana ngaphakathi kweeveki. Ngenxa yezi zinto sele zikhankanyiwe, ukwanda kwesidingo senaliti ezi-3 kunokwenzeka ukuba kunyanzele isabelo sezahlulo, ngalo ndlela kukhuthazwe ubungakanani bemakethi ngokubanzi.
Ngokumalunga nokusetyenziswa kokuphela, icandelo lezibhedlele limele isabelo seshishini liphela esingaphezulu kwama-59% ngowama-2019. Inxalenye enkulu yesabelo ibangelwa kukunyuka kwezibhedlele kwihlabathi liphela. Ukongeza, ukubakho okwandayo kwonyango olusebenzayo lwe-viscosupplementation yezigulana ze-osteoarthritis kwizibhedlele ziya kuqhubela phambili ubungakanani becandelo.
Ngapha koko, ngokwenqaku leendaba elisandula ukupapashwa, kwi-2019, iJamani yayinezibhedlele ezimalunga ne-2000. Ngokugxila okukhulayo kuphuhliso lweziseko zononophelo lwempilo, izibhedlele ziya kubonelela ngempumelelo unyango lwe-viscosupplementation yezigulana ze-osteoarthritis, ngaloo ndlela zivelisa ingeniso ebalulekileyo.
Kwindawo engaphambi kwengingqi, imakethi yokunyuselwa kwe-viscosupplementation yaseSpain iqikelelwa ukuba ibone ukukhula okukhulu kwengeniso ngenxa yezinto ezinje ngokwanda kwenani labemi kunye nenani elikhulayo lamatyala e-osteoarthritis kuloo demographic. Ngapha koko, ngokwedatha epapashwe kutshanje, ngaphezulu kwesigidi sezigidi sabantu abanesifo sehasteoarthritis elizweni uninzi lufuna unyango lwe-viscosupplementation ukuze kuncitshiswe inani leentlungu kumalungu abo.
Isicelo sokwenza ngokwezifiso @ https://www.gminsights.com/roc/4212
Abadlali abakhulu bezentengiso nabo baya besamkela ngakumbi izicwangciso zokukhula kweshishini ezifana nokufumana, intsebenziswano, kunye nokuqaliswa kwemveliso entsha kuzisa ingeniso eninzi. Ukuthatha ngoJuni ka-2019 umzekelo, i-Anika Therapeutics ibonise i-Hyalofast, i-hyaluronic acid-based biodegradable scaffold yayo enokuthi incede ukulungisa i-cartilage kwizigulana.
Indawo yokukhuphisana yentengiso ye-viscosupplementation yentengiso ibandakanya abadlali abanjengoGenzyme Corporation, Wellchem Pharmaceuticals, Zimmer Biomet, Mylan Inc., Johnson & Johnson Services, Chugai Pharmaceutical Co, Bioventus, Aptissen, kunye neAnika Therapeutics phakathi kwabanye.
Isahluko esikhethekileyo seTheyibhile yomxholo
Isahluko 4. Viscosupplementation Market, Ngu Product
4.1. Iimpawu eziphambili zecandelo
4.2. Inaliti enye
4.2.1. Ubungakanani bemakethi, ngommandla, 2015 - 2026 (USD Million)
4.3. 3 Inaliti
4.3.1. Ubungakanani bemakethi, ngommandla, 2015 - 2026 (USD Million)
4.4. 5 Inaliti
4.4.1. Ubungakanani bemakethi, ngommandla, 2015 - 2026 (USD Million)
Isahluko 5. Viscosupplementation Market, NguMthombo weMvelaphi
5.1. Iimpawu eziphambili zecandelo
5.2. Imvelaphi yeAvian
5.2.1. Ubungakanani bemakethi, ngommandla, 2015 - 2026 (USD Million)
5.3. Imvelaphi engeyiyo eyentaka
5.3.1. Ubungakanani bemakethi, ngommandla, 2015 - 2026 (USD Million)
Bhrawuza itafile yonke yokuqulathiweyo (TOC) yale ngxelo @ https://www.gminsights.com/toc/detail/viscosupplementation-market
Lo mxholo upapashwe yinkampani ye-Global Market Insights, Inc. ISebe leendaba leWiredRelease alibandakanyekanga ekwenziweni kwalo mxholo. Ngemibuzo malunga nenkonzo yokukhutshwa kweendaba, nceda usifikelele apha [imeyile ikhuselwe].
